Improving retention and adherence to opioid use disorder treatment through a mobile health intervention
Effectiveness of a CBT-based mHealth Intervention Targeting MOUD Retention, Adherence, and Opioid Use
['FUNDING_OTHER'] · UNIVERSITY OF CALIFORNIA LOS ANGELES · NIH-10857323
This study is testing a new mobile app that uses helpful messages and tips to make it easier for people with opioid use disorders to stick to their buprenorphine treatment and reduce their opioid use.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA LOS ANGELES (nih funded) |
| Locations | 1 site (LOS ANGELES, UNITED STATES) |
| Trial ID | NIH-10857323 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the effectiveness of medications for opioid use disorders (MOUD), particularly buprenorphine, by using a mobile health intervention based on cognitive behavioral therapy (CBT). The approach involves adapting a previously successful SMS-based intervention to address barriers faced by patients in adhering to their treatment. By incorporating feedback from users and healthcare providers, the intervention aims to create a user-friendly platform that supports patients in maintaining their treatment regimen and reducing opioid use.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals aged 21 and older who are undergoing treatment for opioid use disorders and may also be living with HIV.
Not a fit: Patients who are not currently receiving treatment for opioid use disorders or those under 21 years old may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve treatment retention and adherence for individuals with opioid use disorders, leading to better health outcomes.
How similar studies have performed: Previous research has shown success with similar mobile health interventions targeting medication adherence and opioid use reduction among specific populations.
Where this research is happening
LOS ANGELES, UNITED STATES
- UNIVERSITY OF CALIFORNIA LOS ANGELES — LOS ANGELES, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GLASNER, SUZETTE V — UNIVERSITY OF CALIFORNIA LOS ANGELES
- Study coordinator: GLASNER, SUZETTE V
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus